TheBitcoinNews·
PRNewswire, PRNewswire, 4th June 2026, Chainwire
Read full articleEthereum has been under intense selling pressure due to losing the 100-day moving average, which was only reclaimed in April after months. The recent breakdown below a key demand zone has pushed ETH to fresh local lows near $1.75K, while both technical and on-chain indicators continue to favor the bears. Unless buyers reclaim the lost […]
Bankless co-founder David Hoffman has disclosed how he redeployed capital after selling ETH, revealing a new portfolio tilted toward VVV, NEAR, ZEC, HYPE and LIT. The move marks a notable shift for one of Ethereum’s most recognizable public advocates and has triggered debate over whether Hoffman is rotating into a new long-term thesis or chasing a different segment of the market. In a post on X, Hoffman said he “immediately took ~50% of the capital to VVV, NEAR, ZEC, HYPE” after selling ETH. The other half, he said, was held back for dollar-cost averaging into an asset that had not already moved sharply higher. “I left the rest as capital to DCA into something not already up multiples,” Hoffman wrote, adding that NEAR was an exception because it was “~1.40 at the time.” He then said he had completed that second leg of the rotation: “I’ve finished buying LIT with that remaining 50%.” Why Hoffman Chose LIT As Next Major Crypto Bet The disclosure quickly shifted into a broader discussion
SpaceX's IPO could redefine market norms, but governance risks and valuation discrepancies may deter cautious investors. The post SpaceX plans $75B IPO, aims for $1.8T valuation on NASDAQ debut appeared first on Crypto Briefing.
Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $437 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Over 283 Million WLD Tokens
In the June 2026 crypto selloff, Ethereum has fallen harder than Bitcoin, and not by a little. On the worst days, Ethereum (ETH) dropped around 7.5% in 24 hours while Bitcoin fell about 5%, sliding below $1,800 as Bitcoin held…
Some of the AI industry's biggest rivals have put their many, many grievances aside for a common cause: making it harder for people to use their technology to develop biological weapons. In an open letter to US lawmakers, tech leaders are pressing Congress to enact rules closing what they say is an alarming biosecurity gap that could help trigger a global pandemic. Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman are among the signatories urging US lawmakers to require companies selling synthetic DNA and RNA - genetic material that can ordered online and assembled in a lab - to screen purchases for sequences t … Read the full story at The Verge.
The offering would tie fixed cash dividends to a staking-heavy ETH treasury model as Strategy’s preferred stock remains under pressure.
AI-driven regulation of synthetic DNA could reshape biotech markets, favoring larger firms and biosecurity tech, while challenging decentralized science. The post OpenAI and Anthropic urge Congress to regulate synthetic DNA sales as AI lowers bioweapon barriers appeared first on Crypto Briefing.
